Ocular melanoma
MONDO:0006325A melanoma that arises from the structures of the eye or ocular adnexa.
Also known as: eye melanoma, eye melanoma (disease), eyeball of camera-type eye melanoma, eyeball of camera-type eye melanoma (disease), melanoma (disease) of eyeball of camera-type eye, melanoma of eye, melanoma of the eye, ocular melanoma
2933 clinical trials for this condition and its sub-types, 15 tagged with Ocular melanoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Ocular melanoma
-
Uveal melanoma 98 trials · 102 incl. sub-types
8 sub-types
- Malignant choroid melanoma 10 trials Sub-types →
- Iris melanoma 4 trials Sub-types →
- Posterior uveal melanoma 0 trials · 3 incl. sub-types Sub-types →
- Epithelioid cell uveal melanoma 0 trials Sub-types →
- Intermediate cell type uveal melanoma 0 trials Sub-types →
- Mixed cell uveal melanoma 0 trials Sub-types →
- Necrotic uveal melanoma 0 trials Sub-types →
- Spindle cell intraocular melanoma 0 trials Sub-types →
-
Malignant conjunctival melanoma 4 trials
-
Eyelid melanoma 0 trials
-
Malignant cornea melanoma 0 trials
-
Retinal melanoma 0 trials
Most studied deeper sub-types
-
Cancer drug imatinib tested for rare eye melanoma – but trial stops early
Disease control Stopped earlyThis phase II trial tested the drug imatinib in 13 adults with metastatic ocular melanoma, a rare eye cancer that has spread. The goal was to see if imatinib could stop tumor growth for at least 3 months. The trial was terminated early, so the results are limited and it is unclea…
Phase 2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control Stopped earlyThis early-stage trial tested a modified virus (VSV-IFNbetaTYRP1) in 12 patients with advanced melanoma that had spread or could not be removed by surgery. The virus was designed to infect and kill melanoma cells while also boosting the immune system's attack. The main goals were…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC